Mental Process – Page 8

FTC to Sue Major PBMs Over Insulin and Drug Prices Amid Anticompetitive Concerns

10 months ago talkbio0Tagged anticompetitive, Benefit, health companies, Insulin, legal action, manager, PBMs, Pharmaceutical Services, Practice Experience, Prices, United States Federal Trade Commission

FTC, PBMs, Insulin Prices, Drug Prices, Anticompetitive Practices, Pharmacy Benefit Managers, Health Companies, Legal Action

Annovis Bio Reports Promising Phase III Study Results for Buntanetap in Parkinson’s Disease Treatment

10 months ago talkbio0Tagged Annovis, Bio, buntanetap, Cognition, MDS-UPDRS, Motor function (observable entity), Neurodegenerative Disorders, Parkinson 's disease, Parkinson 's Disease Rating Scale, Phase 3 Clinical Trials, Unified - Type of Agreement

Annovis Bio, Buntanetap, Parkinson’s Disease, Phase III Study, Neurodegenerative Disorders, Cognitive Function, Motor Functions, Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

US FTC Intensifies Patent Crusade with Investigation into Teva’s Inhaler IP

10 months ago talkbio0Tagged anticompetitive, Evaluation, Generic competition, Immunoprecipitation, Inhaler, Practice Experience, Teva, United States Federal Trade Commission

US Federal Trade Commission, Teva Pharmaceuticals, Patent Investigation, Inhaler IP, Anticompetitive Practices, Generic Competition

Lilly Collaborates with OpenAI to Develop Novel Antibiotics Against Drug-Resistant Pathogens

10 months ago talkbio0Tagged Antibiotics, Drug Industry, drug-resistant, Eli Lilly, Generative AI, Microbicides, OpenAI, pathogens, Resistance (Psychotherapeutic)

Lilly, OpenAI, Antibiotics, Antimicrobial Resistance, Drug-Resistant Pathogens, Generative AI, Pharmaceutical Industry

Three Ways to Solve the Patient Support Paradox

10 months ago talkbio0Tagged Engaged to be married, Health care facility, Paradox, Patient Flow, Practice Experience

Patient Support Paradox, Patient Experience, Healthcare, Patient Flow, Patient Engagement

Navigating the Complexities of Adding Rare Disease Products to Your Company’s Portfolio

10 months ago talkbio0Tagged Access, biopharmaceutical development, commercialization, Contract Strategy, Identification (Psychology), Market, Rare disease products, regulatory incentives, Technology, value-based

Rare disease products, biopharmaceutical development, commercialization, market access, patient identification, payer contract strategy, value-based contracting, regulatory incentives, emerging technology.